Anavex Life Sciences (AVXL) Tops Q1 EPS by 5c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c